AD has genetic determinants in the form of the early onset (EOAD) or familial AD (FAD), which involves the mutation of one of three genes, amyloid precursor protein (APP), presenilin 1 (PSEN1), or presenilin 2 (PSEN2). This evidence concerns the gene PSEN2 and familial Alzheimer disease.